Silver Cross Pharmaceuticals Llp - Company Profile

It is a pharma limited liability partnership based in Bangalore, Karnataka, India, established in 2013.
2013 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Silver Cross Pharmaceuticals Llp

Silver Cross Pharmaceuticals Llp, a active limited liability partnership, was established on 10 December 2013 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAB-9190. Registered under ROC Roc Bangalore. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Akash Uttam Jain (Designated Partner), Uttam Kumar Pukharaj Jain (Designated Partner). Past directors included Akash Uttam Jain, Vishal Subhas Chand Pipada, Uttam Kumar Pukharaj Jain. Its latest date of accounts and solvency statement 31 March 2023. It is based at No.6, 3Rd Main Road, Ramamohanapura, Gayatri Nagar, Bangalore, Karnataka, 560021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAB-9190

  • Incorporation Date

    10 December 2013

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 12 Year, 2 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** -40.88%
  • Profit Growth **** -10048.00%
  • Ebitda **** 152.89%
  • Total Assets -1.98%
Company report

Silver Cross Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Silver Cross Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Silver Cross Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Akash Uttam Jain Designated Partner 01 Apr 2022 Current
Uttam Kumar Pukharaj Jain Designated Partner 01 Apr 2022 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner 14 May 2023 Past
Pramod Abcsdd Designated Partner 22 May 2015 Past
Pramod Abcsdd Partner 14 May 2023 Past
Pramod Abcsdd Designated Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Silver Cross Pharmaceuticals Llp.

Silver Cross Pharmaceuticals Llp, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.88% decrease. The company also saw a substantial fall in profitability, with a 10048% decrease in profit. The company's net worth witnessed no change by increase of 0%.

Silver Cross Pharmaceuticals Llp revenue growth over time
Silver Cross Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -40.88%
*******
*******
*******
*******
Revenue from Operations
*******
 -40.88%
*******
*******
*******
*******
Total Assets
*******
 -1.98%
*******
*******
*******
*******
Profit or Loss
*******
 -10048.00%
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
 152.89%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Silver Cross Pharmaceuticals Llp?

Unlock access to Silver Cross Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Silver Cross Pharmaceuticals Llp?

Unlock and access historical data on people associated with Silver Cross Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Silver Cross Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Silver Cross Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Silver Cross Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Silver Cross Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Silver Cross Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was documented.

  • Director Appointment

    Akash Uttam Jain was appointed as a Designated Partner was appointed as a Designated Partner on 01 Apr 2022 & has been associated with this company since 3 years 10 months . was recorded as a recent event.

  • Director Appointment

    The activity Uttam Kumar Pukharaj Jain was appointed as a Designated Partner was appointed as a Designated Partner on 01 Apr 2022 & has been associated with this company since 3 years 10 months . was completed.

  • LLP Incorporation

    Silver Cross Pharmaceuticals Llp was registered on 10 Dec 2013 with Roc Bangalore & aged 12 years 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Silver Cross Pharmaceuticals Llp?

The LLPIN of Silver Cross Pharmaceuticals Llp is AAB-9190.

Where is Silver Cross Pharmaceuticals Llp headquartered?

Silver Cross Pharmaceuticals Llp is headquartered at No.6, 3Rd Main Road, Ramamohanapura, Gayatri Nagar, Bangalore, Karnataka, 560021.

When was Silver Cross Pharmaceuticals Llp incorporated?

Silver Cross Pharmaceuticals Llp was incorporated on 10 December 2013.

Who are the current directors of Silver Cross Pharmaceuticals Llp?

The current directors of Silver Cross Pharmaceuticals Llp are

What is the primary industry of Silver Cross Pharmaceuticals Llp?

The primary industry of Silver Cross Pharmaceuticals Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available